Cite

HARVARD Citation

    Wang, X. et al. (2021). Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy. Leukemia & lymphoma. 62 (8), pp. 2022-2025. [Online]. 
  
Back to record